Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.43 times
- The company has been able to generate a Return on Equity (avg) of 0.45% signifying low profitability per unit of shareholders funds
Flat results in Sep 26
Stock is technically in a Bearish range
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
Kothari Ferment. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Kothari Fermentation & Biochem Ltd: Valuation Shifts Signal Changing Market Sentiment
Kothari Fermentation & Biochem Ltd, a micro-cap player in the FMCG sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change, coupled with deteriorating profitability metrics and a strong sell rating upgrade, signals a cautious outlook for investors amid challenging market conditions.
Read More
Kothari Fermentation & Biochem Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals
Kothari Fermentation & Biochem Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 19 Oct 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The micro-cap FMCG stock’s technical trend has improved from mildly bearish to sideways, prompting a reassessment of its near-term outlook. However, the company continues to face significant challenges in financial performance and valuation metrics, which temper enthusiasm among investors.
Read More
Kothari Fermentation & Biochem Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
Kothari Fermentation & Biochem Ltd, a micro-cap player in the FMCG sector, has seen its investment rating downgraded from Sell to Strong Sell as of 12 Oct 2026. This shift reflects deteriorating technical indicators, subdued financial trends, and a reassessment of valuation metrics, signalling heightened caution for investors amid ongoing underperformance relative to benchmarks.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-Nov-2026 | Source : BSEPlease refer to attached annexure w.r.t Newspaper publication of Unaudited Financial Results for quarter and half year ended September 30 2026.
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14 2026 W.R.T. Approval Of Unaudited Financial Results For The Quarter And Half-Year Ended September 30 2026 And Other Matters.
14-Nov-2026 | Source : BSEPlease refer to the attached annexure w.r.t. the Outcome of the Board Meeting dated November 14 2026.
Announcement under Regulation 30 (LODR)-Change in Management
14-Nov-2026 | Source : BSEPlease refer to the attached annexure w.r.t. the Appointment of the Internal Auditor of the Company for F.Y. 2026-27.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Siddhant Kothari (24.85%)
Dheeraj Kumar Lohia (1.36%)
27.13%
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is -8.88% vs -6.34% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is -5,733.33% vs -95.28% in Jun 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -7.40% vs 6.64% in Sep 2024
Growth in half year ended Sep 2025 is -546.15% vs 89.45% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.91% vs 6.71% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -1,808.33% vs 95.85% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -1.84% vs 4.91% in Mar 2025
YoY Growth in year ended Mar 2026 is -469.14% vs 116.50% in Mar 2025